![Avalo Therapeutics Inc](/common/images/company/N_AVTX.png)
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical...
WAYNE, Pa. and ROCKVILLE, Md., June 24, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Paul Varki has joined the Company as its Chief Legal Officer. “We...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.97 | -7.75379696243 | 12.51 | 13 | 11.19 | 6141 | 12.07763455 | CS |
4 | -1.46 | -11.2307692308 | 13 | 13.3 | 10.99 | 9798 | 12.35243242 | CS |
12 | -4.04 | -25.9306803594 | 15.58 | 16 | 8.9174 | 23794 | 11.81252532 | CS |
26 | 7.43 | 180.778588808 | 4.11 | 34.46 | 4.0101 | 347691 | 19.01486254 | CS |
52 | -42.46 | -78.6296296296 | 54 | 71.04 | 3.9501 | 23086909 | 31.94937802 | CS |
156 | -677.26 | -98.3246225319 | 688.8 | 1711.2 | 3.9501 | 8218073 | 39.31330701 | CS |
260 | -677.26 | -98.3246225319 | 688.8 | 1711.2 | 3.9501 | 8218073 | 39.31330701 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.